This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

Semaglutide: No increased risk of neurological or psychiatric outcomes versus other antidiabetic medications, study finds

Semaglutide: No increased risk of neurological or psychiatric outcomes versus other antidiabetic...

UK: An analysis of a large database of US electronic health records (EHRs) supports the safety of glucagon-like peptide 1 (GLP-1) medications. The...
View All

Latest News and Guidelines

Head-to-Head Diabetes Drugs for Weight Loss: Tirzepatide Outperforms Semaglutide in New Study

Head-to-Head Diabetes Drugs for Weight Loss: Tirzepatide Outperforms Semaglutide in New Study

Metformin Reduces Risk of Diabetes by 22%, Results of Latest Meta-analysis

Metformin Reduces Risk of Diabetes by 22%, Results of Latest Meta-analysis

Bright nights, higher diabetes risk: Dimming lights may mitigate this risk, study suggests

Bright nights, higher diabetes risk: Dimming lights may mitigate this risk, study suggests

Type 2 Diabetes

Short and long sleep duration associated with blood vessel damage in recently diagnosed type 2...

Low-GI Mediterranean Diet Enhances Quality of Life for Diabetes-Prone Adults: Study

Low-GI Mediterranean Diet Enhances Quality of Life for Diabetes-Prone Adults: Study

Research Reveals Method to Improve Diabetes and Weight-Loss Drug Performance

Research Reveals Method to Improve Diabetes and Weight-Loss Drug Performance

View All
X